Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06	Rachel Altshuler, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03	Nicholas Hodges, Ph.D.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-06	Howard L. Parnes, M.D.
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-04	Christos Patriotis, Ph.D., M.Sc.
Labaer, Joshua	Arizona State University-Tempe Campus United States	Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck	5R33CA281802-03	Wendy Wang, Ph.D., M.Sc.
Lampe, Paul D.	Fred Hutchinson Cancer Center United States	Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer	5R01CA281801-03	Guillermo Marquez, Ph.D.
Langel, Stephanie N.	Case Western Reserve University United States	Antibody bound bacteria during HPV infection and cervical dysplasia	3R21CA289927-02S1	Goli Samimi, Ph.D., M.P.H.
Langevin, Anne-Marie R.	University Of Texas Hlth Science Center United States	Texas Pediatric NCORP	3UG1CA189855-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Leal, Ana Sofia Mendes	Indiana University Indianapolis United States	Nrf2, immune cells and lung cancer	7R01CA226690-06	Marjorie Perloff, M.D.
Lee, Hakho	Massachusetts General Hospital United States	Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array	5U01CA284982-03	Nicholas Hodges, Ph.D.
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Vanguard Study Administrative Supplement	3UG1CA287011-02S1	Elyse LeeVan, M.D., M.P.H.
Lee, Richard T	Beckman Research Institute/City Of Hope United States	A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy	1R21CA260447-01A1	Rachel Altshuler, Ph.D.
Lee, Juhun	University Of Pittsburgh At Pittsburgh United States	Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis	5R01CA269540-03	Sidney Fu, M.D.
Lehto, Rebecca H	Henry Ford Health + Michigan State University Health Sciences United States	Support for bereaved friend and family caregivers of cancer patients	1R03CA282943-01A1	Brennan Streck, Ph.D., RN, M.P.H.
Lenburg, Marc Elliott	Boston University Medical Campus United States	The Boston University - UCLA Lung Cancer Biomarker Characterization Center	5U2CCA271898-04	Guillermo Marquez, Ph.D.